BD to Present at Jefferies 2019 London Healthcare Conference

Friday, November 15, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

FRANKLIN LAKES, N.J., Nov. 14, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019, at 6:20 a.m. ET.

A live webcast of BD's presentations can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Thursday, November 28, 2019. 

About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.

Contact: Kristen Cardillo, Communications – 201-847-5657 Monique N. Dolecki, Investor Relations – 201-847-5378

 

Cision View original content:http://www.prnewswire.com/news-releases/bd-to-present-at-jefferies-2019-london-healthcare-conference-300958784.html

SOURCE BD (Becton, Dickinson and Company)



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store